MedPath

A study to evaluate the effectiveness of vidanga(Embelia ribes) powder in the management of Gastritis caused by infection (Helicobacter pylori)

Phase 2
Conditions
Health Condition 1: K296- Other gastritis
Registration Number
CTRI/2023/05/053006
Lead Sponsor
Dr S Maniziia
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Symptoms-

1.Sour or bitter eructation/belching

2.nausea, pyrosis, water brash,

3.Indigestion,Loss of appetite

4.Gaseous distension, heaviness of body

5.Positive Helicobacter pylori in upper GI endoscopy yr

Exclusion Criteria

1.Any Cancer of Gastrointestinal tract

2.Past history of Abdominal surgery

3.Pregnant and lactating mother

4.Patients of major systemic illness including Cardiac, hepatobiliary, kidney and IBS

5.Hiatus hernia

6.Major Oral pharyngeal and laryngeal infections

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To Decrease the symptoms of pyrosis,nausea,sour eructation, bloating, abdominal pain <br/ ><br>2.To improve digestion and appetiteTimepoint: 60 days
Secondary Outcome Measures
NameTimeMethod
pper Gastrointestinal Endoscopy with negative H.pylori(RUT)Timepoint: 60 days
© Copyright 2025. All Rights Reserved by MedPath